Zejula (niraparib) capsules is a poly (ADP-ribose) polymerase (PARP) inhibitor.
Zejula (niraparib) is indicated for the maintenance treatment of adult patients with recurrentepithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
